SCHEMBL3398941

SCHEMBL3398941

Cc1nc(-c2cc(Cl)cc(Cl)c2)sc1C(=O)N1CCN(C2CCCC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
THRA P10827 2/20 0.44
THRB P10828 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HRH3 Q9Y5N1 3/20 0.43
HTR2C P28335 4/20 0.42
KMT2A Q03164 1/20 0.42
SCN5A Q14524 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.42
PKM P14618 1/20 0.42
OXTR P30559 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399936 0.90 HRH3 (0.53) CNR1ALDH1A1THRATHRBL3MBTL1
SCHEMBL3401839 0.90 HRH3 (0.53) CNR1ALDH1A1THRATHRBL3MBTL1
SCHEMBL3405417 0.90 KMT2A (0.57) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3398825 0.89 SCN5A (0.54) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3405619 0.89 CNR1 (0.48) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3402530 0.87 CNR1 (0.47) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3403718 0.87 CNR1 (0.54) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3399794 0.86 THRA (0.49) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3406141 0.86 THRA (0.47) CNR1ALDH1A1HPGDTHRATHRB
SCHEMBL3399406 0.86 ALDH1A1 (0.47) CNR1ALDH1A1HPGDTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
WO-2006089076-A9 THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES NEUROGEN CORP (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 CNR1 35/4885ALDH1A1 916/4885HPGD 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.